Literature DB >> 19763384

Botulinum toxin type A and a rehabilitation program in the treatment of Pisa syndrome in Parkinson's disease.

Andrea Santamato, Maurizio Ranieri, Francesco Panza, Stefano Zoccolella, Vincenza Frisardi, Vincenzo Solfrizzi, Maria Teresa Amoruso, Loredana Amoruso, Pietro Fiore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 19763384     DOI： 10.1007/s00415-009-5310-4

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  13 in total

1.  Reversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: case report.

Authors:  Giovanni Cossu; Maurizio Melis; Giannina Melis; Elisabetta Maccioni; Valeria Putzu; Olga Catte; Paolo Francesco Putzu
Journal:  Mov Disord       Date:  2004-10       Impact factor: 10.338

Review 2.  Drug-induced Pisa syndrome (pleurothotonus): epidemiology and management.

Authors:  Toshihito Suzuki; Hisashi Matsuzaka
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

3.  New dystonic syndrome associated with butyrophenone therapy.

Authors:  K Ekbom; H Lindholm; L Ljungberg
Journal:  Z Neurol       Date:  1972

4.  A comparison of pain measurement characteristics of mechanical visual analogue and simple numerical rating scales.

Authors:  D D Price; F M Bush; S Long; S W Harkins
Journal:  Pain       Date:  1994-02       Impact factor: 6.961

Review 5.  Lateral flexion in Parkinson's disease and Pisa syndrome.

Authors:  Fusako Yokochi
Journal:  J Neurol       Date:  2006-12       Impact factor: 4.849

6.  Levodopa/carbidopa/entacapone-induced acute Pisa syndrome in a Parkinson's disease patient.

Authors:  Paolo Solla; Antonino Cannas; Socrate Congia; Gianluca Floris; Rosa Aste; Paolo Tacconi; Maria Giovanna Marrosu
Journal:  J Neurol Sci       Date:  2008-09-23       Impact factor: 3.181

Review 7.  Botulinum toxin treatment of axial and cervical dystonia.

Authors:  Reiner Benecke; Dirk Dressler
Journal:  Disabil Rehabil       Date:  2007-12-15       Impact factor: 3.033

8.  Extensor truncal dystonia: successful treatment with botulinum toxin injections.

Authors:  C L Comella; K M Shannon; J Jaglin
Journal:  Mov Disord       Date:  1998-05       Impact factor: 10.338

Review 9.  Diagnostic criteria for Parkinson disease.

Authors:  D J Gelb; E Oliver; S Gilman
Journal:  Arch Neurol       Date:  1999-01

10.  Botulinum toxin treatment of lateral axial dystonia in Parkinsonism.

Authors:  Laura Bonanni; Astrid Thomas; Sara Varanese; Vincenzo Scorrano; Marco Onofrj
Journal:  Mov Disord       Date:  2007-10-31       Impact factor: 10.338
View more
  1 in total

1.  Improvement of lateral axial dystonia following prismatic correction of oculomotor control disorders in Parkinson's disease.

Authors:  Marco Santilli; Michele Meglio; Sara Varanese; Francesco Lena; Ennio Iezzi; Giovanni Grillea; Nicola Modugno
Journal:  J Neurol       Date:  2016-01-11       Impact factor: 4.849
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.